An anonymous director reports

AVICANNA TO HOLD FULL YEAR 2023 EARNINGS CONFERENCE CALL

Avicanna Inc. invites interested parties to participate in a conference call with Aras Azadian, chief executive officer, and also Phil Cardella, Chief financial officer, where Mr. Azadian and Mr. Cardella will discuss the company's full-year 2023 financial results.

The company will file full-year 2023 financial results after the close of market on April 1, 2024, and will host an earnings call at 8:30 a.m. ET on April 2, 2024. Interested parties may join the earnings call by logging in on-line.

About Avicanna Inc.

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform, including research and development and clinical development that has led to the commercialization of more than 30 products across various market segments.

We seek Safe Harbor.